Skip to content
DraconiticResearch
Search Sources API
206,690 studies31 sourcesUpdated 36 min ago

Oncology

5,185 studies511 in 7 days2,486 in 30 days

Filters
Type
Date
Clear

Latest

5,185 studies

  1. Histone modifications define distinct nucleosome positions in cell-free DNA
    Y. Ou, G. S. Gulati, C. F. Tyndall +18
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxivPMC
  2. Oncogenic PIK3CA mutations cause lineage-selective niche corruption
    O. N. Mruk, A. J. Musk, S. Swaminathan +10
    bioRxivPreprintCC BYFull textOncologybioRxiv
  3. Stromal COL12A1 defines a pro-invasive extracellular matrix niche in appendiceal mucinous neoplasms and pseudomyxoma peritonei
    M. Upton, R. Nagaraju, A. Castaneda +9
    bioRxivPreprintCC BYFull textOncologybioRxiv
  4. An auto-generated ADP-ribosyl-cysteine degron drives DTX2-dependent turnover of PARP7
    Chunsong Yang, Krzysztof Wierbiłowicz, Hyukjin Jang +9
    bioRxivPreprintAll rights reservedFull textOncologybioRxivPMC
  5. Mitochondrial folate transport becomes essential in serine/glycine-starved triple-negative breast cancer
    J. Weber, Y. Lee, V. Papalazarou +3
    bioRxivPreprintCC BYFull textOncologybioRxiv
  6. Dual Role of Cx43 in Enhancing CDK4/6 Inhibitor Response and Promoting the Elimination of Therapy-Induced Senescent Tumor Cells
    P. Carpintero-Fernandez, M. Barturen-Gomez, V. Alvarez +12
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  7. Hepatic stellate cells drive hypoxia-inducible factor (HIF)-dependent metabolic rewiring and proliferation in hepatocellular carcinoma cells
    D. J. Rijlaarsdam, J.-C. Chang, J. B. Helms +2
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  8. Circulating hematopoietic stem and progenitor cells in myeloproliferative neoplasms
    G. Dadi, O. Milman, N. Furer +19
    bioRxivPreprintCC BYFull textOncologybioRxiv
  9. Design, synthesis and biological evaluation of novel artemisinin derivatives as potent P-glycoprotein modulators for overcoming multidrug resistance.
    Jerónimo Laiolo, Artemis Tsirogianni, Cecilia L Barbieri +8
    RSC advancesPeer-reviewedCC BYFull textOncologyEurope PMC
  10. Machine learning-assisted serum Raman spectroscopy for risk stratification in men with suspected prostate cancer: a retrospective proof-of-concept study
    K. Milligan, I. Smith, A. Flugge +3
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  11. Deep Learning-Based Spatial Profiling Identifies MET-Associated Immune Exclusion and Therapeutic Vulnerability Underlying Racial Disparities in Head and Neck Cancer
    Xinyu Cui, Fanghui Chen, Ashley McCook-Veal +7
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxivPMC
  12. Interval colorectal cancer risk by haemoglobin concentration in Australia's National Bowel Cancer Screening Program
    D. Ait Ouakrim, j. Dowty, J. McIntosh +12
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  13. Nonlinear Mixed Effect Modeling of Patient-Reported Outcomes to Improve Treatment Effect Estimation in an Oncology Clinical Trial
    C. Zhang, Q. Li, G. Slim +4
    medRxivPreprintCC BY-NCFull textOncologymedRxiv
  14. Expert recommendations on the management of major and minor toxicities associated with the use of lorlatinib in Latin America
    Luis Corrales, Aknar Freire de Carvalho Calabrich, Aldo Agustin Perfetti +8
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  15. Decoding lipid metabolic reprogramming in pancreatic ductal adenocarcinoma: from tumor–microenvironment crosstalk to therapeutic resistance
    Xingyu Liu, Zitong Ye, Liuyang Wang +9
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  16. Public omics data reuse in gastric cancer: from discovery abundance to translational evidence
    Shuqiong Su, Cong Huang, Bo Yang +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  17. Transcriptional cyclin-dependent kinases as therapeutic targets in bone metastasizing cancers
    Tiina E. Kähkönen, Gergana Galabova, Michael Thormann +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJ
  18. Targeted biopsy with or without systematic biopsy in PI-RADS-stratified prostate biopsy: a risk-adapted narrative review and clinical proposal
    Ye Wu, Yun Wu, Qiang Lu +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  19. Predicting complications after hepatectomy for hepatocellular carcinoma: a narrative review focused on liver failure
    Hongtao Zhang, Jianwang Cai, Zhaoming Yang +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  20. Clinical translation of liquid biopsy in early cancer screening: biofluid selection, model construction, and clinical validation
    Pin Cui, Shu Xu, Xiaohui Lin +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  21. Belzutifan as a possible novel treatment for sporadic central nervous system hemangioblastoma: a report of two cases and focused review of the literature
    Britta L. Bureau, Ataollah Shahbandi, Saman Shabani +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossref
  22. Machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer histopathology: a systematic review and evidence-gap analysis of translational readiness
    Gauhar Dunenova, Aidos Sarsembayev, Ainash Oshibayeva +10
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJ
  23. Fatty liver index and breast cancer risk: age-stratified findings from a prospective electronic health record–based cohort
    Yuqi Ma, Mengyuan Xie, Yanni Li +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJ
  24. A reproducible open-data framework for interpretable breast cancer diagnosis and cytopathology education
    Min Li, Xinxin Zhang, Xiaosu Xie +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJ
  25. Global burden, geographic and sex disparities, and projections to 2050 for salivary gland cancer across G20 countries: a GLOBOCAN 2024 analysis
    Wen Yang, Yuzhen Ma, Chunxia Shu
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefDOAJ